[PHARMA] QoQ Cumulative Quarter Result on 30-Sep-2014 [#3]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
21-Nov-2014
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2014
Quarter
30-Sep-2014 [#3]
Profit Trend
QoQ- 35.45%
YoY- 66.19%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
Cumulative Result
30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 CAGR
Revenue 984,749 471,904 2,122,933 1,495,830 993,744 468,672 1,946,639 -36.59%
PBT 63,668 38,612 125,580 87,726 62,781 38,159 92,997 -22.37%
Tax -15,100 -6,686 -31,355 -30,122 -20,178 -11,513 -36,236 -44.29%
NP 48,568 31,926 94,225 57,604 42,603 26,646 56,761 -9.89%
-
NP to SH 48,011 31,794 93,844 57,147 42,192 26,217 55,200 -8.90%
-
Tax Rate 23.72% 17.32% 24.97% 34.34% 32.14% 30.17% 38.96% -
Total Cost 936,181 439,978 2,028,708 1,438,226 951,141 442,026 1,889,878 -37.47%
-
Net Worth 527,991 528,173 525,526 507,513 502,162 515,022 486,754 5.58%
Dividend
30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 CAGR
Div 36,234 18,123 72,486 41,429 20,707 10,352 41,477 -8.63%
Div Payout % 75.47% 57.00% 77.24% 72.50% 49.08% 39.49% 75.14% -
Equity
30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 CAGR
Net Worth 527,991 528,173 525,526 507,513 502,162 515,022 486,754 5.58%
NOSH 258,819 258,908 258,880 258,935 258,846 258,805 258,911 -0.02%
Ratio Analysis
30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 CAGR
NP Margin 4.93% 6.77% 4.44% 3.85% 4.29% 5.69% 2.92% -
ROE 9.09% 6.02% 17.86% 11.26% 8.40% 5.09% 11.34% -
Per Share
30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 CAGR
RPS 380.48 182.27 820.05 577.69 383.91 181.09 751.85 -36.57%
EPS 18.55 12.28 36.25 22.07 16.30 10.13 21.32 -8.88%
DPS 14.00 7.00 28.00 16.00 8.00 4.00 16.02 -8.61%
NAPS 2.04 2.04 2.03 1.96 1.94 1.99 1.88 5.61%
Adjusted Per Share Value based on latest NOSH - 258,737
30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 CAGR
RPS 68.33 32.74 147.30 103.79 68.95 32.52 135.07 -36.58%
EPS 3.33 2.21 6.51 3.97 2.93 1.82 3.83 -8.92%
DPS 2.51 1.26 5.03 2.87 1.44 0.72 2.88 -8.78%
NAPS 0.3663 0.3665 0.3646 0.3521 0.3484 0.3573 0.3377 5.58%
Price Multiplier on Financial Quarter End Date
30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 CAGR
Date 30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 -
Price 7.13 6.00 4.58 4.63 4.61 4.46 4.45 -
P/RPS 1.87 3.29 0.56 0.80 1.20 2.46 0.59 116.22%
P/EPS 38.44 48.86 12.63 20.98 28.28 44.03 20.87 50.42%
EY 2.60 2.05 7.91 4.77 3.54 2.27 4.79 -33.53%
DY 1.96 1.17 6.11 3.46 1.74 0.90 3.60 -33.39%
P/NAPS 3.50 2.94 2.26 2.36 2.38 2.24 2.37 29.77%
Price Multiplier on Announcement Date
30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 CAGR
Date 17/08/15 18/05/15 23/02/15 21/11/14 21/08/14 14/05/14 24/02/14 -
Price 5.65 6.91 5.28 4.45 4.62 4.70 4.29 -
P/RPS 1.48 3.79 0.64 0.77 1.20 2.60 0.57 89.24%
P/EPS 30.46 56.27 14.57 20.16 28.34 46.40 20.12 31.94%
EY 3.28 1.78 6.87 4.96 3.53 2.16 4.97 -24.25%
DY 2.48 1.01 5.30 3.60 1.73 0.85 3.73 -23.87%
P/NAPS 2.77 3.39 2.60 2.27 2.38 2.36 2.28 13.89%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment